Journal article
Vaccine-derived rotavirus strains in infants in England
- Abstract:
-
Objective:
To describe infants with acute gastroenteritis symptoms in primary and secondary care who have the Rotarix vaccine-derived G1P[8] rotavirus strain identified in their stools.
Design:
This is a prospective national surveillance conducted by Public Health England (PHE). Rotavirus-positive samples from vaccine-eligible children are routinely submitted to PHE for confirmation, and general practitioners are requested to complete a surveillance questionnaire for all cases. The modified Vesikari Score was used to assess severity of gastroenteritis.
Setting:
England, July 2013–September 2016.
Results :
2637 rotavirus strains were genotyped and 215 (8%) identified as the Rotarix vaccine-derived G1P[8] strain. There were no Rotarix vaccine-derived G1P[8] strains detected in unimmunised infants. Rotarix vaccine-derived G1P[8] strains clustered around the time of rotavirus vaccination and were responsible for 82% (107 of 130) of rotavirus-positive samples in 2-month-old infants and 68% (36 of 53) in 3-month-old infants. However, 13 samples were obtained more than 7 weeks after the last vaccination date; 10 of these specimens were from six children who were subsequently diagnosed with severe combined immunodeficiency (SCID). Diarrhoea was the single most common presenting symptom (83.0%) in infants with Rotarix vaccine-derived G1P[8] strains, who were less likely to present with fever, vomiting, dehydration or severe gastroenteritis than infants with wild-type rotavirus infection.
Conclusions:
Rotavirus identified in stools of infants around the time of their routine immunisations is most likely the Rotarix vaccine-derived G1P[8] strain. Infants with undiagnosed SCID at the time of rotavirus immunisation may experience prolonged gastroenteritis symptoms. Most infants with vaccine strains in their stools more than 7 weeks after immunisation had SCID.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 214.4KB, Terms of use)
-
- Publisher copy:
- 10.1136/archdischild-2019-317428
Authors
- Publisher:
- BMJ
- Journal:
- Archives of Disease in Childhood More from this journal
- Volume:
- 105
- Issue:
- 6
- Pages:
- 553-557
- Place of publication:
- England
- Publication date:
- 2019-12-23
- Acceptance date:
- 2019-12-03
- DOI:
- EISSN:
-
1468-2044
- ISSN:
-
0003-9888
- Pmid:
-
31871043
- Language:
-
English
- Keywords:
- Pubs id:
-
1081687
- Local pid:
-
pubs:1081687
- Deposit date:
-
2021-05-24
- ARK identifier:
Terms of use
- Copyright holder:
- Gower et al.
- Copyright date:
- 2020
- Rights statement:
- © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from BMJ at: https://doi.org/10.1136/archdischild-2019-317428
If you are the owner of this record, you can report an update to it here: Report update to this record